These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17919831)

  • 1. A target role for mast cell in the prevention and therapy of hepatic fibrosis.
    Shen DZ
    Med Hypotheses; 2008; 70(4):760-4. PubMed ID: 17919831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis.
    Li Y; Liu FY; Peng YM; Li J; Chen J
    Med Hypotheses; 2007; 69(1):99-103. PubMed ID: 17257770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis.
    Matsunaga Y; Kawasaki H; Terada T
    Am J Gastroenterol; 1999 Jul; 94(7):1923-32. PubMed ID: 10406261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R; Brenner DA
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of bone marrow-derived cultured canine mast cells.
    Lin TY; Rush LJ; London CA
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):37-52. PubMed ID: 16780961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mast cells in progressive renal diseases.
    Holdsworth SR; Summers SA
    J Am Soc Nephrol; 2008 Dec; 19(12):2254-61. PubMed ID: 18776124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of mast cells and hepatic lobule innervation to liver injury.
    Stoyanova II
    Rom J Gastroenterol; 2004 Sep; 13(3):203-9. PubMed ID: 15470532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin: at the heart of the mast cell.
    Reid AC; Silver RB; Levi R
    Immunol Rev; 2007 Jun; 217():123-40. PubMed ID: 17498056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct development of functionally mature tryptase/chymase double-positive connective tissue-type mast cells from primate embryonic stem cells.
    Ma F; Kambe N; Wang D; Shinoda G; Fujino H; Umeda K; Fujisawa A; Ma L; Suemori H; Nakatsuji N; Miyachi Y; Torii R; Tsuji K; Heike T; Nakahata T
    Stem Cells; 2008 Mar; 26(3):706-14. PubMed ID: 17991916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular bases of hepatic fibrogenesis - genetic and therapeutical implications in chronic viral C hepatitis.
    Rogoveanu I; Săndulescu DL; Gheonea DI; Ciurea T; Comănescu V
    Rom J Morphol Embryol; 2008; 49(1):21-5. PubMed ID: 18273498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different approaches to study mast cell functions.
    Sur R; Cavender D; Malaviya R
    Int Immunopharmacol; 2007 May; 7(5):555-67. PubMed ID: 17386403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
    Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
    J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fibrosis -- overview.
    Friedman SL
    Toxicology; 2008 Dec; 254(3):120-9. PubMed ID: 18662740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells in the promotion and limitation of chronic inflammation.
    Metz M; Grimbaldeston MA; Nakae S; Piliponsky AM; Tsai M; Galli SJ
    Immunol Rev; 2007 Jun; 217():304-28. PubMed ID: 17498068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrosis in chronic liver disease.
    Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK
    Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types.
    Saile B; Ramadori G
    Z Gastroenterol; 2007 Jan; 45(1):77-86. PubMed ID: 17236124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.